Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Use of restorative hearing aids associated with decrease in cognitive decline
The use of restorative hearing devices for hearing loss was associated with a 19% decrease in risk for long-term cognitive decline, as well as improvement in cognitive test scores in the short term, researchers reported in JAMA Neurology.
Consumption of ultra-processed foods linked to cognitive decline
Consuming more than 20% of total daily calories from ultra-processed foods was associated with faster decline in cognition and executive function, researchers reported in JAMA Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Dementia more common in patients with RA receiving csDMARDs vs b/tsDMARDs
Dementia is more common in patients with rheumatoid arthritis who receive conventional synthetic disease modifying anti-rheumatic drugs vs. biologics or targeted synthetic treatments, according to data.
Alzheimer’s Network for Treatment and Diagnostics created to collect real-world data
The Alzheimer’s Association is among a group of professional societies and research institutions that have launched the Alzheimer’s Network for Treatment and Diagnostics to collect data on patients treated with novel FDA-approved therapies.
Researchers report ‘striking similarities’ in brains of aging adults, people with COVID-19
Changes in gene expression patterns in the brain associated with natural aging also were observed in the brains of those with severe COVID-19, prompting researchers to emphasize the need for neurological follow-up in recovered individuals.
BLOG: Update to the No Surprises Act good faith estimate requirements for co-providers
On Friday, Dec. 2, 2022, the government snuck out an FAQ delaying implementation of the requirement that good faith estimates under the No Surprises Act must include information from co-providers.
Bromocriptine appears to drop BP, improve arterial stiffness in teens with type 1 diabetes
Bromocriptine, a drug previously used to treat adults with type 2 diabetes and Parkinson’s disease, improved BP and central and peripheral aortic stiffness over 4 weeks in adolescents with type 1 diabetes, researchers reported.
Exercise stalled cognitive decline among adults with mild cognitive impairment
Both moderate aerobic exercise and stretching and balance activities protected against cognitive decline in older adults with mild cognitive impairment, according to research at the Clinical Trials on Alzheimer’s Disease annual meeting.
European Medicines Agency accepts marketing authorization of ALS treatment
Biogen announced that the European Medicines Agency has accepted the marketing authorization application for tofersen, an investigational drug for the treatment of superoxide dismutase 1 ALS.
Patients often misunderstand common medical phrases
Patients frequently misunderstand physician phrases and assign opposite meanings of what was intended, leading to confusion about health outcomes, a study published in JAMA Network Open reported.
-
Headline News
CDC warns of potential overdose risk from online pharmacy prescriptions
October 03, 20242 min read -
Headline News
AAP advocates against school suspensions, expulsions
October 03, 20243 min read -
Headline News
Study: No clear association between pet ownership and brain, heart health
October 03, 20241 min read
-
Headline News
CDC warns of potential overdose risk from online pharmacy prescriptions
October 03, 20242 min read -
Headline News
AAP advocates against school suspensions, expulsions
October 03, 20243 min read -
Headline News
Study: No clear association between pet ownership and brain, heart health
October 03, 20241 min read